The Nordic-American Life Science Conference is an investor and partnering conference gathering healthcare technology executives and investors from North America and the Nordic countries - Sweden, Norway, Finland and Denmark. The conference connects promising, innovative healthcare technology companies and Nordic Life Science organizations with investors, external innovation scouts and business developers in the U.S.
The target audience includes Pharma/Biotech, Diagnostics, Medtech and Digital Health.
The Nordic-American Life Science Conference consists of the main "partnering day" on November 14, but also an "insights day" for all Nordic companies on November 13. The NALSC-team is also happy to be able to offer all NALSC-participants the discounted admission of $795 (Regular price $1295-1495) to the RESI-conference, taking place in New York on November 15.
The Partnering Day on November 14 consists of pitches by Nordic Life Science companies, one-on-one meetings with investors as well as high level panel discussions with investors and business development executives.
The Nordic-American Life Science Conference gives both participating Life Science companies and investors the opportunity to hear formal business presentations as well as informal networking in between sessions.
This format will give participants the possibility to ask questions and discuss their thoughts with experts as well as Nordic fellow companies.
The target audience includes Pharma/Biotech, Diagnostics, Medtech and Digital Health, innovation scouts, business developers and investors.
Companies with an R&D pipeline, academia, and government/authority representatives are welcome to register for this participation type.
Investors, Business Development Executives, and Innovation Scouts from larger companies searching for innovation are welcome to attend the conference for free.
Registrations for this participant type will be confirmed manually by the NALSC-Team
Business service providers are welcome to participate at the NALSC-conference. Please contact the NALSC-team for more details
For other participation types and for sponsorship inquiries, please contact the NALSC-team.
Participation includes: one-on-one meetings, breakfast, networking lunch and coffee. Please note that the number of company pitches is limited and for selected companies only.
If you are uncertain about your company's elgibility, please contact Jessica Mansourati at
firstname.lastname@example.org or +1 (312) 781 6210
The Nordic-American Life Science Conference Team offers all participants discounted admission $795 (regular admission $1295-1495) to the RESI conference in NYC on November 15th, the day after NALSC.
The RESI (Redefining Early Stage Investments) Conference in New York brings together fundraising CEOs and early stage investors from around the globe, providing the opportunity for dialogue and relationship building, with the goal of eventual capital allocations.
For more information about RESI, and to sign up, please click here
Please note that the discounted admission to the RESI-conference is exclusive for NALSC-participants. A promotion code will be sent out to registered participants upon request.
Approximate transport times/prices from the airports to the venue by car:
Business Sweden helps global companies to establish business and research activities in Sweden. Our industry experts can connect you with the right business and investment opportunities, being the best partner when investing in Sweden.
DNB is Norway’s largest financial services group, and a top tier healthcare bank in the US. Our customers include global pharma, biotech and medical device companies headquartered in the North America, Europe, and Australia.
Nasdaq is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence.